News, Resources, Updates
A scientific hub to keep you informed about our latest research and company updates.
InnoSer joins the Eurostars funded project ‘LEMONAID’
LEMONAID takes on the challenge of developing a new drug against Diffuse Large B-Cell Lymphoma (DLBCL) tumors to ultimately reduce drug resistance and relapse potential for patients. InnoSer supports this ambition by its expertise in combined in-vitro and in-vivo...
InnoSer meets you at knowledge for growth event
[EDIT]: This event is now hold digitally, and we are looking forward to talking to you at one of our virtual meetings. Detailed schedules to be announced soon! Organized by flanders.bio since it's establishment in 2004, knowledge for growth brings over 1300 biotech,...
InnoSer welcomes Wim Tiest as its Chief Technology Officer
As of April 2020, Wim Tiest has joined InnoSer in the role of Chief Technology Officer (CTO) and as part of the company management team. Wim holds a MSc in biochemical engineering and in artificial intelligence, both from the KU Leuven. He has built his professional...
PDX/O oncology platform developments at InnoSer
Despite the challenging times for the life sciences sector during coronavirus restrictions, we’ve been fortunate enough and well prepared to continue with the development of our PDX/O platform for oncology research. On a weekly basis we receive patient tumor samples...
Press Release: InnoSer continues to deliver critical in-vivo and in-vitro services
Press release | Leiden, 19 March 2020InnoSer continues to deliver critical in-vivo and in-vitro services COVID-19 restrictions call for attention to prevent fully halting life sciences operationsInnoSer remains committed to continuing its in-vivo and in-vitro research...
Taking Precautions Against Coronavirus
Following the most recent governmental advice and regulations, we have decided to take preventative measures against the fast spread of COVID-19. The health and interests of our customers, employees and other stakeholders are our top priority. In order to minimize the...
info@innoserlaboratories.com